Skip to main content
SpringerLink
Log in

Novolizer®

A Viewpoint by Peter Haidl

  • Adis Drug Profile
  • Guest Commentary
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Use of tradenames is for product identification purposes only and does not imply endorsement.

Author information

Authors and Affiliations

  1. Centre of Pneumology, Kloster Grafschaft Hospital, Schmallenberg, Germany

    Peter Haidl

Authors
  1. Peter Haidl
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haidl, P. Novolizer®. Drugs 63, 2447 (2003). https://doi.org/10.2165/00003495-200363220-00011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-200363220-00011

Search

Navigation